Gene Therapies Get a $3 Billion Vote of Confidence
(Bloomberg Opinion) -- Gene therapies — treatments that replace faulty genetic code to fight deadly diseases — are still in their infancy. Just two have been approved in the U.S. so far. But they got a big vote of confidence after the close of U.S. trading Monday when Japanese drugmaker Astellas Pharma